bs-44020P-Biotin [Conjugated Protein]
Recombinant SARS-Cov-2 N protein (EG.5/BA.4/BA.4.6)（P13L，DEL31-33，R203K，G204R，S413R）,N-His, Biotin Conjugated
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Entrez Gene: 43740568

Swiss Prot: P0DTC2

Source: Recombinant SARS-Cov-2 N protein (EG.5/BA.4/BA.4.6)（P13L，DEL31-33，R203K，G204R，S413R）is expressed in E.coli with N-His. It contains the amino acid sequence of 1-419/419

Storage Buffer: Lyophilized from 0.22um filtered solution in 20mM PB (pH 7.4). 5% trehalose is added as a protectant before lyophilization.

Storage: The product should be stored at -70°C or -20°C.

Background:

The SARS-CoV-2 spike (S) protein is the target of vaccine design efforts to end the COVID-19 pandemic. Despite a low mutation rate, isolates with the D614G substitution in the S protein appeared early during the pandemic, and are now the dominant form worldwide. Here, we analyze the D614G mutation in the context of a soluble S ectodomain construct.

Sequence: 1-419/419

Conjugation: Biotin

Excitation/ Emission: N/A

Size: 100µg, 500µg, 20µg

Applications: Others

Predicted Molecular Weight: 47.1


Cross Reactive Species: Others

For research use only. Not intended for diagnostic or therapeutic use.